ConductScience.org, home

Paper8555470

Complete remission in severe aplastic anemia after high-dose cyclophosphamide without bone marrow transplantation.

Brodsky RA and 2 others. Blood, 1996. Cited by 139 papers, by iCite.

Cite this record

ConductScience Library. Complete remission in severe aplastic anemia after high-dose cyclophosphamide without bone marrow transplantation. Papers, record 8555470. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8555470

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Complete remission in severe aplastic anemia after high-dose cyclophosphamide without bone marrow transplantation.
PubMed
Journal
Blood
PubMed
Year
1996
PubMed
Publication types
Clinical Trial, Comparative Study, Journal Article, Multicenter Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
139
iCite
Relative citation ratio, by iCite
4.38
iCite
Revised in PubMed
2021-02-16
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Brodsky RAR A
2Sensenbrenner LLL L
3Jones RJR J

Source PubMed

Download CSV of authors

Topics16

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Anemia, AplasticMajor topic
CyclophosphamideMajor topic
Immunosuppressive AgentsMajor topic
Acquired Immunodeficiency Syndrome
Adolescent
Adult
Bone Marrow
Child
Cyclosporine
Female
Follow-Up Studies
Humans
Male
Regeneration
Remission Induction
Treatment Outcome

Source PubMed

Download CSV of topics

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
CA15396NCI NIH HHSUnited StatesP01CA015396PubMed and NIH

Source NIH RePORTER

Download CSV of grants

Trials1

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's record
NCT00005778High-Dose Intravenous (IV) Cyclophosphamide Versus Monthly IV CyclophosphamideBackground

Source ClinicalTrials.gov

Download CSV of trials

Cited by36

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 139 citations.

PMIDTitleJournalYearIn PapersSource
41694401Low-dose cyclophosphamide combined with standard immunosuppressive therapy improves early response rates in severe aplastic anemia.Front Immunol2026https://conductscience.org/library/papers/41694401PubMed
39576169High-dose Cyclophosphamide Without Stem Cell Rescue in Autoimmune Diseases: A Systematic Review.Eur J Rheumatol2024https://conductscience.org/library/papers/39576169PubMed
38669341Modified Delphi panel consensus recommendations for management of severe aplastic anemia.Blood Adv2024https://conductscience.org/library/papers/38669341PubMed
33113600[How I treat refractory sever aplastic anemia].Zhonghua Xue Ye Xue Za Zhi2020https://conductscience.org/library/papers/33113600PubMed
29143887Diagnosis and Treatment of Aplastic Anemia.Curr Treat Options Oncol2017https://conductscience.org/library/papers/29143887PubMed
29100887A pharmacologically immunosuppressed mouse model for assessing influenza B virus pathogenicity and oseltamivir treatment.Antiviral Res2017https://conductscience.org/library/papers/29100887PubMed
28975138High-dose cyclophosphamide without stem cell rescue in immune-mediated necrotizing myopathies.Neurol Neuroimmunol Neuroinflamm2017https://conductscience.org/library/papers/28975138PubMed
28228650Haematopoietic stem cell transplantation for autoimmune diseases.Nat Rev Rheumatol2017https://conductscience.org/library/papers/28228650PubMed
27589232
Non-invasive Imaging of Sendai Virus Infection in Pharmacologically Immunocompromised Mice: NK and T Cells, but not Neutrophils, Promote Viral Clearance after Therapy with Cyclophosphamide and Dexamethasone.
PLoS Pathog2016https://conductscience.org/library/papers/27589232PubMed
27467367High-dose Cyclophosphamide is Effective Therapy for Pediatric Severe Aplastic Anemia.J Pediatr Hematol Oncol2016https://conductscience.org/library/papers/27467367PubMed
23605367The optimal immunosuppressive therapy for aplastic anemia.Int J Hematol2013https://conductscience.org/library/papers/23605367PubMed
23358715Repeated treatment with high dose cyclophosphamide for severe autoimmune diseases.Am J Blood Res2013https://conductscience.org/library/papers/23358715PubMed
23222381Alternative immunosuppression in patients failing immunosuppression with ATG who are not transplant candidates: Campath (Alemtuzumab).Bone Marrow Transplant2013https://conductscience.org/library/papers/23222381PubMed
22053283Aplastic anemia: immunosuppressive therapy in 2010.Pediatr Rep2011https://conductscience.org/library/papers/22053283PubMed
21865410Treatment of relapsing-remitting multiple sclerosis with high-dose cyclophosphamide induction followed by glatiramer acetate maintenance.Mult Scler2012https://conductscience.org/library/papers/21865410PubMed
21495931Clinical management of aplastic anemia.Expert Rev Hematol2011https://conductscience.org/library/papers/21495931PubMed
21447004Natural history of paroxysmal nocturnal hemoglobinuria clones in patients presenting as aplastic anemia.Eur J Haematol2011https://conductscience.org/library/papers/21447004PubMed
21358440High-dose cyclophosphamide without stem cell rescue in 207 patients with aplastic anemia and other autoimmune diseases.Medicine (Baltimore)2011https://conductscience.org/library/papers/21358440PubMed
21295330High-dose cyclophosphamide without stem cell rescue for the treatment of refractory Behcet's disease.Semin Arthritis Rheum2011https://conductscience.org/library/papers/21295330PubMed
21169833High-dose chemotherapy and multiple sclerosis.Curr Opin Oncol2011https://conductscience.org/library/papers/21169833PubMed

See all 36 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/8555470

GET https://conductscience.org/api/papers/v1/8555470/cited_by?page=2